Results 111 to 120 of about 21,933 (136)

Imatinib mesylate

American Journal of Health-System Pharmacy, 2001
openaire   +3 more sources

Imatinib Mesylate

2011
openaire   +2 more sources

Imatinib mesylate-sensitive blast crisis immediately after discontinuation of imatinib mesylate therapy in chronic myelogenous leukemia: Report of two cases

American Journal of Hematology, 2004
Junichi Tsukada
exaly  

Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma

Annals of Oncology, 2013
Marta Giorgia Podda, Alberto Garaventa, Roberto Luksch   +2 more
exaly  

Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases

Annals of Medicine, 2003
Kari Eklund
exaly  

Subdural Hematomas during CML Therapy with Imatinib Mesylate

Leukemia and Lymphoma, 2004
K W Song, H A Messner, K Yee
exaly  

Dysregulation of bone remodeling by imatinib mesylate

Blood, 2010
Timothy Hughes, Kate Vandyke, Andrew Zannettino   +2 more
exaly  

Cost-utility analysis of imatinib mesylate for the treatment ofchronic myelogenous leukemia in the chronic phase

Clinical Therapeutics, 2004
Paul Scuffham, Sue Ward
exaly  

Imatinib Mesylate

2017
openaire   +1 more source

Imatinib mesylate causes hypopigmentation in the skin

Cancer, 2003
Anne Tsao, Moshe Talpaz
exaly